Pain is independently associated with reduced health related quality of life in people with psychosis

Psychiatry Research

Volumn 230, Issue 2, 2015, Pages 585-591

  Stubbs, Brendon ^a   Gardner Sood, Poonam ^b   Smith, Shubulade ^a   Ismail, Khalida ^c   Greenwood, Kathryn ^d   Patel, Anita ^e   Farmer, Ross ^a,f   Gaughran, Fiona ^a  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF SUSSEX   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Pain; Physical health; Psychosis

Indexed keywords

ADULT; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; ENGLAND; FEMALE; HUMAN; MALE; MIDDLE AGED; PAIN; PSYCHOLOGY; PSYCHOTIC DISORDERS; QUALITY OF LIFE;

ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PSYCHOTIC DISORDERS; QUALITY OF LIFE;

EID: 84947081073     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.10.008     Document Type: Article

References (56)

1. Department of Health (DOH), 2009. The Chief Medical Officers Annual Report. London, UK.
2. Abdulla A., Bone M., Adams N., Elliott A.M., Jones D., Knaggs R., Martin D., Sampson E.L., Schofield P. Evidence-based clinical practice guidelines on management of pain in older people. Age Ageing 2013, 151-153.
3. American Psychiatric Association, 2002. Multiaxial assessment. In: Diagnostic and Statistical Manual of Mental Disorders (4th edn, text revised) (DSM-IV-TR). APA.
4. Bonnot O., Anderson G.M., Cohen D., Willer J.C., Tordjman S. Are patients with schizophrenia insensitive to pain? A reconsideration of the question. Clin. J. Pain 2009, 25(3):244-252.
5. Breivik H., Collett B., Ventafridda V., Cohen R., Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur. J. Pain 2006, 10(4):287-333.
6. Buckley P.F., Miller B.J., Lehrer D.S., Castle D.J. Psychiatric comorbidities and schizophrenia. Schizophr. Bull. 2009, 35(2):383-402.
7. CLeeland C. Measurement of pain by subjective report. Advances in Pain Research and Therapy 1991, 12:391-403. NY: Raven Press, New York.
8. Calvert M., Blazeby J., Altman D.G., Revicki D.A., Moher D., Brundage M.D. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA: J. Am. Med. Assoc. 2013, 309(8):814-822.
9. Calvert M., Kyte D., Duffy H., Gheorghe A., Mercieca-Bebber R., Ives J., Draper H., Brundage M., Blazeby J., King M. Patient-reported outcome (PRO) assessment in clinical trials: a systematic review of guidance for trial protocol writers. PLoS ONE 2014, 9(10):1-13.
10. Chaturvedi S.K. Prevalence of chronic pain in psychiatric patients. Pain 1987, 29(2):231-237.
11. Craig C.L., Marshall A.L., Sjöström M., Bauman A.E., Booth M.L., Ainsworth B.E., Pratt M., Ekelund U., Yngve A., Sallis J.F., Oja P. International physical activity questionnaire: 12-country reliability and validity including commentary by Bassett DR Jr. Med. Sci. Sports Exerc. 2003, 35(8):1381-1396.
12. de Almeida J.G., Braga P.E., Neto F.L., de Mattos Pimenta C.A. Chronic pain and quality of life in schizophrenic patients. Rev. Bras. Psiquiatr. 2013, 35(1):13-20.
13. De Hert M., Correll C.U., Bobes J., Cetkovich-Bakmas M., Cohen D., Asai I., Detraux J., Gautam S., Möller H.-J., Ndetei D.M., Newcomer J.W., Uwakwe R., Leucht S. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry: Off. J. World Psychiatr. Assoc. 2011, 10(1):52-77.
14. Elman I., Zubieta J.-K., Borsook D. The missing p in psychiatric training: why it is important to teach pain to psychiatrists. Arch. Gen. Psychiatry 2011, 68(1):12-20.
15. Engels G., Francke A.L., van Meijel B., Douma J.G., de Kam H., Wesselink W., Houtjes W., Scherder E.J.A. Clinical pain in schizophrenia: a systematic review. J. Pain: Off. J. Am. Pain Soc. 2014, 15(5):457-467.
16. EQ-5D, 1990. UK (English) 1990 EuroQol Group EQ-5D& is a trade mark of the EuroQol Group.
17. Field A.P. Discovering Statistics Using IBM SPSS Statistics: and Sex and Drugs and Rock''n' Roll 2013, Sage publications, London. fourth edition.
18. Fishbain D.A., Cutler R., Rosomoff H.L., Rosomoff R.S. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin. J. Pain 1997, 13(2):116-137.
19. Gaskin D.J., Richard P. The economic costs of pain in the United States. J. Pain 2012, 13(8):715-724.
20. Gaughran F., Stahl D., Ismail K., Atakan Z., Lally J., Gardner-Sood P., Patel A., David A., Hopkins D., Harries B., Lowe P., Orr D., Arbuthnot M., Murray R., Greenwood K., Smith S. Improving physical health and reducing substance use in psychosis - randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trial. BMC Psychiatry 2013, 13(1):263.
21. Hasselström J., Liu-Palmgren J., Rasjö-Wrååk G. Prevalence of pain in general practice. Eur. J. Pain 2002, 6(5):375-385.
22. Heider D., Angermeyer M.C., Winkler I., Schomerus G., Bebbington P.E., Brugha T., Azorin J.-M., Toumi M. A prospective study of quality of life in schizophrenia in three European countries. Schizophr. Res. 2007, 93(1-3):194-202.
23. Jarcho J.M., Mayer E.A., Jiang Z.K., Feier N.A., London E.D. Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain (03043959) 2012, 153(4):744-754.
24. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
25. Kuritzky A., Mazeh D., Levi A. Headache in schizophrenic patients: a controlled study. Cephalalgia 1999, 19(8):725-727.
26. Laursen T.M., Munk-Olsen T., Agerbo E., Gasse C., Mortensen P.B. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch. Gen. Psychiatry 2009, 66(7):713-720.
27. Leucht S., Kane J.M., Etschel E., Kissling W., Hamann J., Engel R.R. Linking the PANSS, BPRS, and CGI: clinical Implications. Neuropsychopharmacology 2006, 31(10):2318-2325.
28. Melzack R. The short-form McGill pain questionnaire. Pain 1987, 30(2):191-197.
29. Mitchell A., Vancampfort D., De Hert M., Stubbs B. Do people with mental illness receive adequate smoking cessation advice? A systematic review and meta-analysis. Gen. Hosp. Psychiatry 2015, 37(1):14-23.
30. Mitchell A.J., Lord O., Malone D. Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis. Br. J. Psychiatry 2012, 201(6):435-443.
31. Mitchell A.J., Malone D., Doebbeling C.C. Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br. J. Psychiatry: J. Ment. Sci. 2009, 194(6):491-499.
32. Mitchell A.J., Pereira I.E.S., Yadegarfar M., Pepereke S., Mugadza V., Stubbs B. Breast cancer screening in women with mental illness: comparative meta-analysis of mammography uptake. Br. J. Psychiatry: J. Ment. Sci. 2014, 205(6):428-435.
33. Mitchell A.J., Vancampfort D., Sweers K., van Winkel R., Yu W., De Hert M. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis. Schizophr. Bull. 2013, 39(2):306-318.
34. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134:382-389.
35. Murray C.J.L., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., Ezzati M., Shibuya K., Salomon J.A., Abdalla S., Aboyans V., Abraham J., Ackerman I., Aggarwal R., Ahn S.Y., Ali M.K., Alvarado M., Anderson H.R., Anderson L.M., Andrews K.G., Atkinson C., Baddour L.M., Bahalim A.N., Barker-Collo S., Barrero L.H., Bartels D.H., Basáñez M.-G., Baxter A., Bell M.L., Benjamin E.J., Bennett D., Bernabé E., Bhalla K., Bhandari B., Bikbov B., Bin Abdulhak A., Birbeck G., Black J.A., Blencowe H., Blore J.D., Blyth F., Bolliger I., Bonaventure A., Boufous S., Bourne R., Boussinesq M., Braithwaite T., Brayne C., Bridgett L., Brooker S., Brooks P., Brugha T.S., Bryan-Hancock C., Bucello C., Buchbinder R., Buckle G., Budke C.M., Burch M., Burney P., Burstein R., Calabria B., Campbell B., Canter C.E., Carabin H., Carapetis J., Carmona L., Cella C., Charlson F., Chen H., Cheng A.T.-A., Chou D., Chugh S.S., Coffeng L.E., Colan S.D., Colquhoun S., Colson K.E., Condon J., Connor M.D., Cooper L.T., Corriere M., Cortinovis M., de Vaccaro K.C., Couser W., Cowie B.C., Criqui M.H., Cross M., Dabhadkar K.C., Dahiya M., Dahodwala N., Damsere-Derry J., Danaei G., Davis A., De Leo D., Degenhardt L., Dellavalle R., Delossantos A., Denenberg J., Derrett S., Des Jarlais D.C., Dharmaratne S.D., Dherani M., Diaz-Torne C., Dolk H., Dorsey E.R., Driscoll T., Duber H., Ebel B., Edmond K., Elbaz A., Ali S.E., Erskine H., Erwin P.J., Espindola P., Ewoigbokhan S.E., Farzadfar F., Feigin V., Felson D.T., Ferrari A., Ferri C.P., Fèvre E.M., Finucane M.M., Flaxman S., Flood L., Foreman K., Forouzanfar M.H., Fowkes F.G.R., Fransen M., Freeman M.K., Gabbe B.J., Gabriel S.E., Gakidou E., Ganatra H.A., Garcia B., Gaspari F., Gillum R.F., Gmel G., Gonzalez-Medina D., Gosselin R., Grainger R., Grant B., Groeger J., Guillemin F., Gunnell D., Gupta R., Haagsma J., Hagan H., Halasa Y.A., Hall W., Haring D., Haro J.M., Harrison J.E., Havmoeller R., Hay R.J., Higashi H., Hill C., Hoen B., Hoffman H., Hotez P.J., Hoy D., Huang J.J., Ibeanusi S.E., Jacobsen K.H., James S.L., Jarvis D., Jasrasaria R., Jayaraman S., Johns N., Jonas J.B., Karthikeyan G., Kassebaum N., Kawakami N., Keren A., Khoo J.-P., King C.H., Knowlton L.M., Kobusingye O., Koranteng A., Krishnamurthi R., Laden F., Lalloo R., Laslett L.L., Lathlean T., Leasher J.L., Lee Y.Y., Leigh J., Levinson D., Lim S.S., Limb E., Lin J.K., Lipnick M., Lipshultz S.E., Liu W., Loane M., Ohno S.L., Lyons R., Mabweijano J., MacIntyre M.F., Malekzadeh R., Mallinger L., Manivannan S., Marcenes W., March L., Margolis D.J., Marks G.B., Marks R., Matsumori A., Matzopoulos R., Mayosi B.M., McAnulty J.H., McDermott M.M., McGill N., McGrath J., Medina-Mora M.E., Meltzer M., Mensah G.A., Merriman T.R., Meyer A.-C., Miglioli V., Miller M., Miller T.R., Mitchell P.B., Mock C., Mocumbi A.O., Moffitt T.E., Mokdad A.A., Monasta L., Montico M., Moradi-Lakeh M., Moran A., Morawska L., Mori R., Murdoch M.E., Mwaniki M.K., Naidoo K., Nair M.N., Naldi L., Narayan K.M.V., Nelson P.K., Nelson R.G., Nevitt M.C., Newton C.R., Nolte S., Norman P., Norman R., O'Donnell M., O'Hanlon S., Olives C., Omer S.B., Ortblad K., Osborne R., Ozgediz D., Page A., Pahari B., Pandian J.D., Rivero A.P., Patten S.B., Pearce N., Padilla R.P., Perez-Ruiz F., Perico N., Pesudovs K., Phillips D., Phillips M.R., Pierce K., Pion S., Polanczyk G.V., Polinder S., Pope C.A., Popova S., Porrini E., Pourmalek F., Prince M., Pullan R.L., Ramaiah K.D., Ranganathan D., Razavi H., Regan M., Rehm J.T., Rein D.B., Remuzzi G., Richardson K., Rivara F.P., Roberts T., Robinson C., De Leòn F.R., Ronfani L., Room R., Rosenfeld L.C., Rushton L., Sacco R.L., Saha S., Sampson U., Sanchez-Riera L., Sanman E., Schwebel D.C., Scott J.G., Segui-Gomez M., Shahraz S., Shepard D.S., Shin H., Shivakoti R., Singh D., Singh G.M., Singh J.A., Singleton J., Sleet D.A., Sliwa K., Smith E., Smith J.L., Stapelberg N.J.C., Steer A., Steiner T., Stolk W.A., Stovner L.J., Sudfeld C., Syed S., Tamburlini G., Tavakkoli M., Taylor H.R., Taylor J.A., Taylor W.J., Thomas B., Thomson W.M., Thurston G.D., Tleyjeh I.M., Tonelli M., Towbin J.A., Truelsen T., Tsilimbaris M.K., Ubeda C., Undurraga E.A., van der Werf M.J., van Os J., Vavilala M.S., Venketasubramanian N., Wang M., Wang W., Watt K., Weatherall D.J., Weinstock M.A., Weintraub R., Weisskopf M.G., Weissman M.M., White R.A., Whiteford H., Wiebe N., Wiersma S.T., Wilkinson J.D., Williams H.C., Williams S.R.M., Witt E., Wolfe F., Woolf A.D., Wulf S., Yeh P.-H., Zaidi A.K.M., Zheng Z.-J., Zonies D., Lopez A.D., AlMazroa M.A., Memish Z.A. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
36. Nielsen J., Juel J., Al-Zuhairi K.S.M., Friis R., Graff C., Kanters J.K., Jensen S.E. Unrecognised myocardial infarction in patients with schizophrenia. Acta Neuropsychiatr. 2015, 27(2):106-112.
37. Potvin S., Marchand S. Hypoalgesia in schizophrenia is independent of antipsychotic drugs: a systematic quantitative review of experimental studies. Pain 2008, 138(1):70-78.
38. Ruggeri M., Nosè M., Bonetto C., Cristofalo D., Lasalvia A., Salvi G., Stefani B., Malchiodi F., Tansella M. Changes and predictors of change in objective and subjective quality of life: multiwave follow-up study in community psychiatric practice. Br. J. Psychiatry: J. Ment. Sci. 2005, 187:121-130.
39. Saarni S.I., Viertiö S., Perälä J., Koskinen S., Lönnqvist J., Suvisaari J. Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br. J. Psychiatry 2010, 197(5):386-394.
40. Smith D.J., Langan J., McLean G., Guthrie B., Mercer S.W. Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study. BMJ Open 2013, 3(4).
41. Soundy A., Freeman P., Stubbs B., Probst M., Coffee P., Vancampfort D. The transcending benefits of physical activity for individuals with schizophrenia: a systematic review and meta-ethnography. Psychiatry Res. 2014, 220(1-2):11-19.
42. Soundy A., Roskell C., Stubbs B., Vancampfort D. Selection, use and psychometric properties of physical activity measures to assess individuals with severe mental illness: a narrative synthesis. Arch. Psychiatr. Nurs. 2014, 28(2):135-151.
43. Stochl J., Croudace T., Perez J., Birchwood M., Lester H., Marshall M., Amos T., Sharma V., Fowler D., Jones P.B. National Eden Study Team. Usefulness of EQ-5D for evaluation of health-related quality of life in young adults with first-episode psychosis. Qual Life Res. 2013, 22(5):1055-1063.
44. Strassnig M., Brar J.S., Ganguli R. Body mass index and quality of life in community-dwelling patients with schizophrenia. Schizophr. Res. 2003, 62(1-2):73-76.
45. Stubbs B., Eggermont L., Mitchell A.J., De Hert M., Correll C.U., Soundy A., Rosenbaum S., Vancampfort D. The prevalence of pain in bipolar disorder: a systematic review and large-scale meta-analysis. Acta Psychiatr. Scand. 2015, 131(2):75-88.
46. Stubbs B., Gardner-Sood P., Smith S., Ismail K., Greenwood K., Farmer R., Gaughran F. Sedentary behaviour is associated with elevated C-reactive protein levels in people with psychosis. Schizophr. Res. 2015, 168(1-2):461-464.
47. Stubbs B., Mitchell A.J., De Hert M., Correll C.U., Soundy A., Stroobants M., Vancampfort D. The prevalance and moderators of clinical pain in people with schizophrenia: a systematic review and large scale meta-analysis. Schizophr. Res. 2014, 160:1-8.
48. Stubbs B., Probst M., Soundy A., Parker A., De Herdt A., De Hert M., Mitchell A.J., Vancampfort D. Physiotherapists can help implement physical activity programmes in clinical practice. Br. J. Psychiatry: J. Ment. Sci. 2014, 204(2):164.
49. Stubbs, B., Thompson, T., Acaster, S., Vancampfort, D., Gaughran, F., Correll, CU., 2015c. Decreased Pain Sensitivity Among People with Schizophrenia: A Meta-analysis of Experimental Pain Induction Studies. Pain. [Epub ahead of print].
50. Uthman O.A., van der Windt D.A., Jordan J.L., Dziedzic K.S., Healey E.L., Peat G.M., Foster N.E. Exercise for lower limb osteoarthritis: systematic review incorporating trial sequential analysis and network meta-analysis. BMJ (Clinical Research Ed.) 2013, 347. (f5555-f).
51. Vancampfort D., De Hert M., De Herdt A., Soundy A., Stubbs B., Bernard P., Probst M. Associations between perceived neighbourhood environmental attributes and self-reported sitting time in patients with schizophrenia: a pilot study. Psychiatry Res. 2014, 215(1):33-38.
52. Vancampfort D., De Hert M., Stubbs B., Ward P.B., Rosenbaum S., Soundy A., Probst M. Negative symptoms are associated with lower autonomous motivation towards physical activity in people with schizophrenia. Compr. Psychiatry 2014, 56:128-132.
53. Vancampfort D., de Hert M., Vansteenkiste M., de Herdt A., Scheewe T.W., Soundy A., Stubbs B., Probst M. The importance of self-determined motivation towards physical activity in patients with schizophrenia. Psychiatry Res. 2013, 210(3):812-818.
54. Vancampfort D., Probst M., Scheewe T., Maurissen K., Sweers K., Knapen J., De Hert M. Lack of physical activity during leisure time contributes to an impaired health related quality of life in patients with schizophrenia. Schizophr. Res. 2011, 129(2-3):122-127.
55. Watson G.D., Chandarana P.C., Merskey H. Relationships between pain and schizophrenia. Br. J. Psychiatry 1981, 138:33-36.
56. Wojakiewicz A., Januel D., Braha S., Prkachin K., Danziger N., Bouhassira D. Alteration of pain recognition in schizophrenia. Eur. J. Pain 2013, 17(9):1385-1392.